A virus-agnostic nasal spray called ‘INNA-051’ was designed to increase innate immunity and prevent respiratory illnesses ...

Aucta Pharmaceuticals is pleased to announce the late January launch of PYQUVI oral suspension 22.75 mg/mL.  PYQUVI, a corticosteroid indicated for the treatment of Duchenne muscular dystrophy (DMD) ...

The Netherlands' MedTech startups lead healthcare innovation through AI diagnostics, medical devices, and digital health ...

Scientists have developed a nasal spray that is safe and effective in protecting against various strains of the flu, an ...

The need for more effective protection against influenza continues to grow, as the virus consistently causes significant illness and mortality worldwide New human clinical data from Leyden ...

Leyden Laboratories B.V. (the "Company" or "Leyden Labs") today announced landmark preclinical and clinical data in Science ...

The company noted that its Phase 2 community study, known as POSITS, has started with the first participants being dosed in ...

A Phase 2 trial is testing a weekly intranasal spray that primes early immune defenses to reduce respiratory virus illness.

A new nasal spray vaccine for H5N1 bird flu has shown promising early results, raising hopes it could one day be used to help ...

A case demonstrating sustained remission of exercise-induced asthma, allergic oropharyngeal symptoms, and recurrent ...

India, Feb. 1 -- A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate,cb1, capable of generating broad immunity ...

ETHealthworld.com brings latest nasal spray news, views and updates from all top sources for the Indian Health industry.